ALLUCENT CONSULTING

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ALLUCENT CONSULTING wurde als Wortmarke am 15.09.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 06. Juli 2023

Markenform Wortmarke
Aktenzeichen 1712003
Länder Brasilien Weißrussland Kanada Europäische Gemeinschaft Großbritannien Georgien Israel Indien Serbien Russland Ukraine
Basismarke US Nr. 97318068, 17. März 2022
Anmeldedatum 15. September 2022
Ablaufdatum 15. September 2032

Markeninhaber

271 Waverly Oaks Rd. Suite 208
Waltham MA 02452
US

Markenvertreter

101 California Street San Francisco CA 94111 US

Waren und Dienstleistungen

09 Downloadable computer application software for use in connection with the collection, tracking, retrieval, validation, summarization, statistical analysis and presentation of data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; downloadable computer application software for providing telehealth, telemedicine, remote care and virtual health care services to patients; downloadable computer application software for use in connection with collection, tracking, retrieval, validation, summarization, statistical analysis and presentation of remotely gathered patient-generated health data for use in clinical studies
35 Data management, namely, abstraction and collection of medical data from clinical tests for business purposes; market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries
42 Programming of software for managing and collecting patient-generated health data for scientific research purposes; cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; hosting of web-based portal for study sponsors and contract research organizations (CROS) to build programs, enroll members, automate actions, and visualize/analyze data in connection with clinical studies; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production; consulting services for others in the field of design, planning, and implementation project management of clinical trials; analysis of statistical data relating to clinical trials for pharmaceuticals, biotechnology, medical devices and diagnostics for scientific research
45 Development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance in drug, biologic, cosmetic and medical device development
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
28. Juni 2023 2023/26 Gaz EM Ablehnung
01. Mai 2023 2023/18 Gaz GB Ablehnung
21. April 2023 2023/17 Gaz RU Ablehnung
15. September 2022 2023/4 Gaz US Eintragung

ID: 141712003